Compounds, Compositions, and Methods
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 6 of these applications claim priority to application 15/624,566, filed Jun 15, 2017. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,932,325 | Compounds, Compositions, and Methods In force · High confidence UsedRemaining | Denali Therapeutics Inc. | In force | High confidence | ||
| US 10,590,114 | Compounds, Compositions, and Methods In force · Medium confidence | Denali Therapeutics Inc. | In force | Medium confidence | ||
| US 11,111,235 | Compounds, Compositions, and Methods In force · Medium confidence | Denali Therapeutics Inc. | In force | Medium confidence | ||
| US 11,591,316 | Compounds, Compositions, and Methods In force · Medium confidence | Denali Therapeutics Inc. | In force | Medium confidence | ||
| US 11,834,439 | Compounds, Compositions, and Methods In force · High confidence | Denali Therapeutics Inc. | In force | High confidence | ||
| US 12,747,232 | Compounds, Compositions, and Methods In force · Medium confidence | Denali Therapeutics Inc. | In force | Medium confidence | ||
| Application 15/624,566 | Compounds, Compositions, and Methods Abandoned Abandoned Jan 16, 2018 | Denali Therapeutics Inc. | Abandoned | Abandoned Jan 16, 2018 | ||
| Application 18/386,492 | Compounds, Compositions, and Methods Abandoned Abandoned Jun 18, 2024 | Denali Therapeutics Inc. | Abandoned | Abandoned Jun 18, 2024 |
8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by Denali Therapeutics Inc..
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.